An arabinogalactan from fruits of Lycium barbarum L. inhibits production and aggregation of Aβ42

Authors:

Abstract
No abstract available
Funding Information
  • Key Basic Study on Function and Bioactivity of Lycium barbarum L
  • Ningxia and Chinese Academy of Sciences, New Drug Creation and Manufacturing Program (2017ZX09305-003)
  • National Natural Science Foundation of China (31500651, 31230022)
  • Ministry of Science and Technology
  • People Republic of China, Program of Shanghai Subject Chief Scientist (16XD1404500)

This publication has 36 references indexed in Scilit: